Increased MANF Expression in the Inferior Temporal Gyrus in Patients With Alzheimer Disease

Increased MANF Expression in the Inferior Temporal Gyrus in Patients With Alzheimer Disease

Alzheimer disease (AD) is an aging-related disorder linked to endoplasmic reticulum (ER) stress. The main pathologic feature of AD is the presence of extracellular senile plaques and intraneuronal neurofibrillary tangles (NFTs) in the brain. In neurodegenerative diseases, the unfolded protein respon...

Full description

Bibliographic Details
Main Authors:	Xue-Chun Liu, Xiu-Hong Qi, Hui Fang, Ke-Qing Zhou, Qing-Song Wang, Gui-Hai Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-04-01
Series:	Frontiers in Aging Neuroscience
Subjects:	Alzheimer disease cerebral cortex endoplasmic reticulum stress MANF hyperphosphorylated tau senile plaque
Online Access:	https://www.frontiersin.org/articles/10.3389/fnagi.2021.639318/full

Similar Items

Emerging Roles for Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) in Pancreatic Beta Cells and Diabetes
by: Tatiana Danilova, et al.
Published: (2018-10-01)

MRI Dynamically Evaluates the Therapeutic Effect of Recombinant Human MANF on Ischemia/Reperfusion Injury in Rats
by: Xian-Yun Wang, et al.
Published: (2016-09-01)

C. elegans MANF Homolog Is Necessary for the Protection of Dopaminergic Neurons and ER Unfolded Protein Response
by: Cory Richman, et al.
Published: (2018-08-01)

Berberine Reduces Aβ42 Deposition and Tau Hyperphosphorylation via Ameliorating Endoplasmic Reticulum Stress
by: Yue Wu, et al.
Published: (2021-07-01)

Trophic Factors in Inflammation and Regeneration: The Role of MANF and CDNF
by: Pedro Sousa-Victor, et al.
Published: (2018-11-01)

Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer’s Disease
by: Yan Zhou, et al.
Published: (2018-02-01)

MANF Is Neuroprotective in Early Stages of EAE, and Elevated in Spinal White Matter by Treatment With Dexamethasone
by: Jinhan Nam, et al.
Published: (2021-07-01)

MANF: A New Player in the Control of Energy Homeostasis, and Beyond
by: Su Yang, et al.
Published: (2018-11-01)

Unconventional neurotrophic factors CDNF and MANF: Structure, physiological functions and therapeutic potential
by: Maria Lindahl, et al.
Published: (2017-01-01)

In vivo screening reveals interactions between Drosophila Manf and genes involved in the mitochondria and the ubiquinone synthesis pathway
by: Riitta Lindström, et al.
Published: (2017-06-01)

Human-Specific Regulation of Neurotrophic Factors MANF and CDNF by microRNAs
by: Julia Konovalova, et al.
Published: (2021-09-01)

Tau and mTOR: The Hotspots for Multifarious Diseases in Alzheimer's Development
by: Zeba Mueed, et al.
Published: (2019-01-01)

Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) Is Highly Expressed in Mouse Tissues With Metabolic Function
by: Tatiana Danilova, et al.
Published: (2019-11-01)

Downregulation of DmMANF in Glial Cells Results in Neurodegeneration and Affects Sleep and Lifespan in Drosophila melanogaster
by: Lucyna Walkowicz, et al.
Published: (2017-11-01)

Pathological Tau From Alzheimer’s Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau in vivo
by: Jin Miao, et al.
Published: (2019-03-01)

An evolutionary perspective on the role of mesencephalic astrocyte-derived neurotrophic factor (MANF): At the crossroads of poriferan innate immune and apoptotic pathways
by: Dayane Sereno, et al.
Published: (2017-09-01)

Melatonin in Alzheimer’s Disease
by: Jian-Zhi Wang, et al.
Published: (2013-07-01)

MANF Produced by MRL Mouse-Derived Mesenchymal Stem Cells Is Pro-regenerative and Protects From Osteoarthritis
by: Gautier Tejedor, et al.
Published: (2021-03-01)

Curcuminoids and resveratrol as anti-Alzheimer agents
by: Oliver B. Villaflores, et al.
Published: (2012-12-01)

Hyperphosphorylation of Tau Associates With Changes in Its Function Beyond Microtubule Stability
by: Alejandra D. Alonso, et al.
Published: (2018-10-01)

Liposome delivery systems for the treatment of Alzheimer’s disease
by: Ross C, et al.
Published: (2018-12-01)

Investigations into Tyrosine-mediated Hyperphosphorylation and Aggregation of Tau Protein via Ferrocene Bioconjugates
by: Rains, Meghan Krystyna
Published: (2012)

Investigations into Tyrosine-mediated Hyperphosphorylation and Aggregation of Tau Protein via Ferrocene Bioconjugates
by: Rains, Meghan Krystyna
Published: (2012)

Genetic and non-genetic factors responsible for mitochondrial failure and Alzheimer’s disease
by: Gao Kuo, et al.
Published: (2014-01-01)

Therapeutic Strategies to Target Calcium Dysregulation in Alzheimer’s Disease
by: Maria Calvo-Rodriguez, et al.
Published: (2020-11-01)

Mesencephalic astrocyte-derived neurotrophic factor (MANF) protects against Aβ toxicity via attenuating Aβ-induced endoplasmic reticulum stress
by: Shengchun Xu, et al.
Published: (2019-02-01)

Structure Based Design and Molecular Docking Studies for Phosphorylated Tau Inhibitors in Alzheimer’s Disease
by: Jangampalli Adi Pradeepkiran, et al.
Published: (2019-03-01)

The Impact of Intermittent and Repetitive Cold Stress Exposure on Endoplasmic Reticulum Stress and Instability of Atherosclerotic Plaques
by: Ming-Xiang Dai, et al.
Published: (2014-07-01)

Surfen and oxalyl surfen decrease tau hyperphosphorylation and mitigate neuron deficits in vivo in a zebrafish model of tauopathy
by: Seyedeh Maryam Alavi Naini, et al.
Published: (2018-03-01)

Neurons Expressing Pathological Tau Protein Trigger Dramatic Changes in Microglial Morphology and Dynamics
by: Rahma Hassan-Abdi, et al.
Published: (2019-11-01)

Zebrafish Models to Study New Pathways in Tauopathies
by: Clément Barbereau, et al.
Published: (2021-04-01)

Neuroprotective effects of tenuigenin on neurobehavior, oxidative stress, and tau hyperphosphorylation induced by intracerebroventricular streptozotocin in rats
by: Xiao-Bo Huang, et al.
Published: (2018-01-01)

DJ-1 (PARK7) is associated with 3R and 4R tau neuronal and glial inclusions in neurodegenerative disorders
by: Ravindran Kumaran, et al.
Published: (2007-10-01)

Natural polyphenols effects on protein aggregates in Alzheimer's and Parkinson's prion-like diseases
by: Aline Freyssin, et al.
Published: (2018-01-01)

Targeting Tau to Treat Clinical Features of Huntington's Disease
by: Maria Masnata, et al.
Published: (2020-11-01)

Advances in the mechanisms of atherosclerosis vulnerable plague and endoplasmic reticulum stress
by: Zhong Zhang, et al.
Published: (2016-05-01)

Similarities and Differences in the Pattern of Tau Hyperphosphorylation in Physiological and Pathological Conditions: Impacts on the Elaboration of Therapies to Prevent Tau Pathology
by: Antoine Duquette, et al.
Published: (2021-01-01)

Melatonin receptor stimulation by agomelatine prevents Aβ-induced tau phosphorylation and oxidative damage in PC12 cells
by: Yao K, et al.
Published: (2019-01-01)

Alois alzheimer
by: Padmapriya Gorjilli
Published: (2015-01-01)

Tau Pathology in Parkinson's Disease
by: Xue Zhang, et al.
Published: (2018-10-01)

Cannot write session to /tmp/vufind_sessions/sess_kdavhni487080jgj6qad3mi0eb